开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09939 开拓药业-B

已收盘 02-25 16:08:33

2.630

+0.020

+0.77%

最高2.670	最低2.600	成交量79.45万
今开2.670	昨收2.610	日振幅2.68%
总市值13.12亿	流通市值13.12亿	总股本4.99亿
成交额208.60万	换手率0.16%	流通股本4.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09939","market":"HK","secType":"STK","nameCN":"开拓药业-B","latestPrice":2.63,"timestamp":1772006913672,"preClose":2.61,"halted":0,"volume":794500,"delay":0,"changeRate":0.007662835249042153,"floatShares":499000000,"shares":499000000,"eps":-0.360537,"marketStatus":"已收盘","change":0.02,"latestTime":"02-25 16:08:33","open":2.67,"high":2.67,"low":2.6,"amount":2086020,"amplitude":0.02682,"askPrice":2.63,"askSize":33500,"bidPrice":2.62,"bidSize":5000,"shortable":0,"etf":0,"ttmEps":-0.367,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772069400000},"marketStatusCode":5,"adr":0,"listingDate":1590076800000,"exchange":"SEHK","adjPreClose":2.61,"openAndCloseTimeList":[[1771983000000,1771992000000],[1771995600000,1772006400000]],"volumeRatio":0.538558,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09939","defaultTab":"news","newsList":[{"id":"2614701674","title":"红日药业：甲苯磺酰胺注射液（PTS）的上市许可持有人是天津红日健达康医药科技有限公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2614701674","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614701674?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:36","pubTimestamp":1772008576,"startTime":"0","endTime":"0","summary":"请问：1. PTS项目的合作模式、各方权益分配及收益分成具体是怎样的？红日药业持有红日健达康12.5%股份，该产品销售收入目前对公司影响较小。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500025804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","09939","159938","BK1574","300026","BK1515","BK0239","BK0188","BK0077"],"gpt_icon":0},{"id":"2614709299","title":"2月25日常山药业涨8.87%，医药LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2614709299","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614709299?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:28","pubTimestamp":1772008090,"startTime":"0","endTime":"0","summary":"证券之星消息，2月25日常山药业涨8.87%，收盘报46.63元，换手率3.89%，成交量35.69万手，成交额16.67亿元。融资融券方面近5日融资净流出8882.48万，融资余额减少；融券净流入0.0，融券余额增加。重仓常山药业的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为国泰基金的医药LOF。医药LOF目前规模为6.54亿元，最新净值0.567，较上一交易日下跌0.11%，近一年上涨4.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500025456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1161","BK1515","BK0172","BK0239","09939","BK1574","BK0070","300255"],"gpt_icon":0},{"id":"2614653705","title":"吉林敖东：积极推进医药营销改革","url":"https://stock-news.laohu8.com/highlight/detail?id=2614653705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614653705?lang=zh_cn&edition=full","pubTime":"2026-02-25 15:27","pubTimestamp":1772004433,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东02月25日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年7月，腾讯健康与康美药业签署战略合作协议后，经营有了较好改观。请问吉林敖东是否有引进有先进经营理念的战略合作者的想法？目前公司正积极推进医药营销改革，通过整合各营销板块、组建营销事业群，优化管理体系、形成发展合力、统一资源，实现营销突破，助力公司高质量发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500018642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0074","BK0201","BK1161","000623","09939","159938","BK1574","BK1515","BK0012","BK0028","BK0086","BK0239","BK0188"],"gpt_icon":0},{"id":"2614708058","title":"联化科技：公司医药业务致力于为客户提供端到端一体化服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2614708058","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614708058?lang=zh_cn&edition=full","pubTime":"2026-02-25 15:00","pubTimestamp":1772002843,"startTime":"0","endTime":"0","summary":"证券之星消息，联化科技(002250)02月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司的小核酸业务实现批量出货了吗？有无小核酸原料药管线？联化科技回复：公司医药业务致力于为客户提供端到端一体化服务，持续努力提高业务水平跟随客户发展。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500018276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK1574","BK0118","BK1161","002250","09939","BK0229","159938","BK0188","BK0028","BK0070"],"gpt_icon":0},{"id":"2614741747","title":"国内首个患者智能匹配专利技术落地，翼帆医药重构临床药物试验招募逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2614741747","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614741747?lang=zh_cn&edition=full","pubTime":"2026-02-25 13:11","pubTimestamp":1771996286,"startTime":"0","endTime":"0","summary":"近日，水滴公司旗下北京翼帆风顺医药科技有限公司自主研发的 “临床药物试验患者智能匹配技术” 正式获得国家发明专利：临床药物试验患者的匹配方法、装置及计算机设备。临床药物试验是新药上市的关键环节，而精准招募符合入排条件的患者是试验顺利推进的核心前提。据行业相关数据统计，超过80%的临床试验因招募延迟而受阻。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","159938","BK4539","WDH","BK4509","BK1161","BK4173","09939"],"gpt_icon":0},{"id":"2613791611","title":"圣泉集团（605589）披露收购控股子公司尚博医药部分股权暨关联交易公告，2月24日股价上涨4.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613791611","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613791611?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:32","pubTimestamp":1771925575,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，圣泉集团报收于32.69元，较前一交易日上涨4.17%，最新总市值为276.68亿元。公司于近日披露《关于收购控股子公司济南尚博医药股份有限公司股权暨关联交易的公告》。公告显示，济南圣泉集团股份有限公司拟以自有资金429.00万美元收购英国宝欧信特有限公司持有的控股子公司济南尚博医药股份有限公司13.50%股权。本次交易完成后，圣泉集团对尚博医药的持股比例将由76.50%增至90.00%，不导致合并报表范围变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400033209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK1161","BK1574","605589","09939","159938","BK1515"],"gpt_icon":0},{"id":"2613954527","title":"故乡烟火经济｜生产线满负荷运转，千名医药人春节守岗保供","url":"https://stock-news.laohu8.com/highlight/detail?id=2613954527","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613954527?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:33","pubTimestamp":1771921980,"startTime":"0","endTime":"0","summary":"\n                                                生产线上的机器轰鸣与药房里的温暖守候，共同织就了一张畅通无阻的药品供应网。                                                [全文]\n","market":"sh","thumbnail":"https://media.bjnews.com.cn/image/2026/02/24/5690384712296637109.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/image/2026/02/24/5690384712296637109.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1771916410129211.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1771916410129211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK1574","09939","159938","BK1515","BK1161"],"gpt_icon":0},{"id":"2613795592","title":"2月24日泽璟制药跌9.28%，汇添富创新医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613795592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613795592?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:26","pubTimestamp":1771921591,"startTime":"0","endTime":"0","summary":"证券之星消息，2月24日泽璟制药跌9.28%创60日新低，收盘报85.66元，换手率2.04%，成交量5.41万手，成交额4.72亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共84家，其中持有数量最多的公募基金为汇添富基金的汇添富创新医药混合A。汇添富创新医药混合A目前规模为72.69亿元，最新净值1.7449，较上一交易日下跌0.89%，近一年上涨39.79%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400030092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1574","688266","BK1161","09939","BK1515","159938"],"gpt_icon":0},{"id":"2613927798","title":"浙江医药(600216.SH)拟参投合伙企业 投向银发经济/医药大健康领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2613927798","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613927798?lang=zh_cn&edition=full","pubTime":"2026-02-24 15:50","pubTimestamp":1771919448,"startTime":"0","endTime":"0","summary":"合伙企业由中信医疗健康股权投资私募基金管理(北京)有限公司担任普通合伙人、执行事务合伙人和基金管理人。合伙企业重点投向银发经济/医药大健康领域的目标公司，促使被投资企业价值迅速提升，实现基金的设立目标，同时尽合理商业努力获得本基金资本的增值，并努力实现全体合伙人收益的最大化，从而实现多赢的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK1161","BK1515","600216","BK0191","09939","BK0028","BK1574","BK0239","159938"],"gpt_icon":0},{"id":"2613571159","title":"劲方医药-B盘中异动 股价大跌5.09%报28.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613571159","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613571159?lang=zh_cn&edition=full","pubTime":"2026-02-24 13:02","pubTimestamp":1771909343,"startTime":"0","endTime":"0","summary":"2026年02月24日下午盘13时02分，劲方医药-B股票出现波动，股价快速下挫5.09%。截至发稿，该股报28.740港元/股，成交量13.0736万股，换手率0.04%，振幅4.56%。资金方面，该股资金流入112.399万港元，流出231.809万港元。劲方医药-B股票所在的药品行业中，整体跌幅为0.73%。其相关个股中，宝济药业-B、海西新药、君圣泰医药-B涨幅较大，振幅较大的相关个股有宝济药业-B、君圣泰医药-B、信达生物，振幅分别为10.61%、8.84%、7.17%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224130224a4c17795&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224130224a4c17795&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1515","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"2613731204","title":"每日卖空追踪 | 劲方医药-B 02月23日卖空量成交1.1万股，卖空比例为3.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613731204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613731204?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835432,"startTime":"0","endTime":"0","summary":"劲方医药-B北京时间02月23日，涨5.43%，卖空量成交1.1万股，较上一交易日减少89.48%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163410a4be7dd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163410a4be7dd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09939","BK1515","02595"],"gpt_icon":0},{"id":"2613205233","title":"劲方医药-B盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613205233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613205233?lang=zh_cn&edition=full","pubTime":"2026-02-23 10:24","pubTimestamp":1771813466,"startTime":"0","endTime":"0","summary":"2026年02月23日早盘10时24分，劲方医药-B股票出现波动，股价快速拉升5.01%。截至发稿，该股报30.160港元/股，成交量8.31万股，换手率0.02%，振幅6.48%。劲方医药-B股票所在的药品行业中，整体涨幅为0.79%。其相关个股中，中国同辐、九源基因、劲方医药-B涨幅较大，振幅较大的相关个股有泰德医药、精优药业、宝济药业-B，振幅分别为9.85%、8.33%、6.86%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223102426a4bda0ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223102426a4bda0ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1574","BK1161","BK1515","09939"],"gpt_icon":0},{"id":"2613781173","title":"蛋白降解(TPD)：26年看自免管线临床突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2613781173","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613781173?lang=zh_cn&edition=full","pubTime":"2026-02-23 00:00","pubTimestamp":1771776000,"startTime":"0","endTime":"0","summary":"本周涨幅前五的个股为：振德医疗、欧林生物、美好医疗、万泽股份、博拓生物TPD 赛道研发火热，26 年重点关注自免管线临床进展。蛋白降解技术在自身免疫疾病进展迅速，STAT6、IRAK4、IRF5、VAV1、NLRP3、NEK7 等热门小分子靶点备受关注。2026 年开始，众多自免TPD 靶点将迎来数据读出，或进入到临床关键性阶段，值得重点关注。国内公司中，苑东生物、诺诚健华均有VAV1 分子胶产品布局，海思科、先声药业均有STAT6 靶点布局，百济神州亦有IRAK4 靶点布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223171634a7157e24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223171634a7157e24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1515","HK0000252152.HKD","HK0000252160.HKD","BK1588","LU0307460666.USD","09939","LU1303224171.USD","HK0000500386.USD","BK1161","BK1500","06160","LU1719994722.HKD","09606","LU2328871848.SGD","BK1574","LU1770034418.SGD","LU2543165471.USD","LU1969619763.USD","02096","LU1251922891.USD","LU0588546209.SGD"],"gpt_icon":0},{"id":"2613063293","title":"每日卖空追踪 | 劲方医药-B 02月20日卖空量成交5.36万股，卖空比例为9.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613063293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613063293?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576231,"startTime":"0","endTime":"0","summary":"劲方医药-B北京时间02月20日，跌4.01%，卖空量成交5.36万股，较上一交易日减少41.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163418a70cd067&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163418a70cd067&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1574","BK1161","09939","BK1515"],"gpt_icon":0},{"id":"2613293034","title":"劲方医药-B02月20日遭主力抛售34.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613293034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613293034?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:15","pubTimestamp":1771575353,"startTime":"0","endTime":"0","summary":"02月20日, 劲方医药-B股价跌4.01%，报收28.72元，成交金额1555.8万元，换手率0.16%，振幅8.09%，量比0.97。劲方医药-B今日主力资金净流出34.8万元，上一交易日主力净流出173.6万元。该股近5个交易日下跌10.17%，主力资金累计净流出364.9万元；近20日主力资金累计净流入555.9万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161925a4b5ddf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161925a4b5ddf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","09939","BK1574","02595"],"gpt_icon":0},{"id":"2612430848","title":"2026年医药圈啥走向？","url":"https://stock-news.laohu8.com/highlight/detail?id=2612430848","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612430848?lang=zh_cn&edition=full","pubTime":"2026-02-17 08:18","pubTimestamp":1771287516,"startTime":"0","endTime":"0","summary":"站在2026年伊始，医药财经AI来聊聊医药行业将是啥情况。中国银河证券说，2026年医药行业大概率要往上走了，重点看那些有真技术的公司。中国药企到了“收庄稼”的时候2025年，中国药企干了两件大事：一是新药批得多——全年批了76个创新药，比2024年的48个多出一大截，创了历史新高。美国银行证券甚至预测，2026年中国药企往外卖药的交易还得创新高。2026年，就是看这一步能不能踩实的时候。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217091101a4abd1e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217091101a4abd1e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0320764599.SGD","LU1046422090.SGD","BK1515","BK1141","BK1576","BK1574","LU2045819591.USD","02359","LU0708995583.HKD","LU2125910500.SGD","LU0052750758.USD","BK1583","LU2242644610.SGD","09939"],"gpt_icon":0},{"id":"2612243314","title":"每日卖空追踪 | 同源康医药-B 02月16日卖空量成交1500股，卖空比例为1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612243314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612243314?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230627,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月16日，跌0.31%，卖空量成交1500股，较上一交易日减少94.12%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163339a4a9f7a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163339a4a9f7a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","09939","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2611721771","title":"劲方医药-B盘中异动 早盘股价大涨7.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611721771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611721771?lang=zh_cn&edition=full","pubTime":"2026-02-16 09:33","pubTimestamp":1771205624,"startTime":"0","endTime":"0","summary":"2026年02月16日早盘09时33分，劲方医药-B股票出现波动，股价快速拉升7.08%。劲方医药-B股票所在的药品行业中，整体涨幅为0.07%。其相关个股中，英硅智能、康臣药业、海西新药涨幅较大，振幅较大的相关个股有海普瑞、英硅智能、复星医药，振幅分别为6.10%、5.78%、5.28%。劲方医药-B公司简介：劲方医药科技(上海)有限公司是一家专注于创新药物研发的中国公司。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021609334495413f0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021609334495413f0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1161","09939","02595"],"gpt_icon":0},{"id":"2611147275","title":"华金证券：四季度陆股通持仓继续上升 有色、通信获加仓较多","url":"https://stock-news.laohu8.com/highlight/detail?id=2611147275","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611147275?lang=zh_cn&edition=full","pubTime":"2026-02-15 10:35","pubTimestamp":1771122932,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华金证券发布研报称，四季度陆股通持仓继续上升，主板持仓占比小幅上升，周期板块持仓占比上升。整体来看，2025年四季度陆股通持仓总规模接近2.59万亿元，较上季度环比增加54.06亿元。该行预计，2026年一季度陆股通资金可能继续加仓核心资产、科技和周期等行业。有色金属、通信超配比上升较多，医药、食品、银行及非银超配比下降较多。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260215104313a4a61da4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260215104313a4a61da4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","03750","02338","02359","BK1515","BK1161","02318","BK1574"],"gpt_icon":0},{"id":"2611145949","title":"每周股票复盘：威高血净（603014）拟85.11亿收购普瑞医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2611145949","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611145949?lang=zh_cn&edition=full","pubTime":"2026-02-15 02:19","pubTimestamp":1771093150,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘，威高血净报收于40.73元，较上周的40.07元上涨1.65%。本周，威高血净2月13日盘中最高价报41.41元。威高血净当前最新总市值170.15亿元，在医疗器械板块市值排名16/129，在两市A股市值排名1257/5189。本周关注点公司公告汇总：威高血净拟85.11亿元收购普瑞医药100%股权，构成重大资产重组。交易对方为公司实际控制人陈学利控制的企业，发行价格为31.29元/股，标的资产评估值为85.11亿元，业绩承诺期内承诺净利润分别为6.40亿元、7.20亿元、7.84亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","09939","BK1515","BK1574","BK1161","603014","159938"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintor.com.cn","stockEarnings":[{"period":"1week","weight":-0.0509},{"period":"1month","weight":-0.0777},{"period":"3month","weight":0.2488},{"period":"6month","weight":0.1757},{"period":"1year","weight":1.3304},{"period":"ytd","weight":0.3316}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.006},{"period":"3month","weight":0.0255},{"period":"6month","weight":0.0637},{"period":"1year","weight":0.1392},{"period":"ytd","weight":0.0374}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"开拓药业有限公司是一家主要从事创新药产品研发的投资控股公司。该公司产品致力于解决未满足临床需求的疾病领域，管线主要涵盖皮科（如脱发、痤疮等）及肿瘤适应症。该公司在皮科领域有两款核心药物KX-826及GT20029。该公司在其他疾病领域包括转移性去势抗性前列腺癌（mCRPC）、肝癌、特发性肺纤维化、恶性血液疾病及多种实体瘤等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.020286},{"month":2,"riseRate":0.666667,"avgChangeRate":0.170846},{"month":3,"riseRate":0.4,"avgChangeRate":0.084454},{"month":4,"riseRate":0.6,"avgChangeRate":0.421119},{"month":5,"riseRate":0.6,"avgChangeRate":0.045244},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.066873},{"month":7,"riseRate":0.666667,"avgChangeRate":0.132768},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.071497},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.129033},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.103242},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073526},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.185801}],"exchange":"SEHK","name":"开拓药业-B","nameEN":"KINTOR PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开拓药业-B,09939,开拓药业-B股票,开拓药业-B股票老虎,开拓药业-B股票老虎国际,开拓药业-B行情,开拓药业-B股票行情,开拓药业-B股价,开拓药业-B股市,开拓药业-B股票价格,开拓药业-B股票交易,开拓药业-B股票购买,开拓药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}